Literature DB >> 30282483

Evaluation of early treatment response to radiotherapy for HCC using pre- and post-treatment MRI.

So Hee Song1, Woo Kyoung Jeong1, Dongil Choi1, Young Kon Kim1, Hee Chul Park2, Jeong Il Yu2.   

Abstract

Keywords:  Hepatocellular carcinoma; Response Evaluation Criteria in Solid Tumors (RECIST); magnetic resonance imaging; prognosis; radiotherapy

Mesh：

Year:  2018        PMID： 30282483     DOI： 10.1177/0284185118805253

Source DB:  PubMed          Journal:  Acta Radiol        ISSN： 0284-1851            Impact factor:   1.990


× No keyword cloud information.
  4 in total

1.  Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.

Authors:  Wei Song; Jingjing Zhang; Qingxin Xia; Miaomiao Sun
Journal:  Cell Cycle       Date:  2019-09-29       Impact factor: 4.534

2.  Virtual Screening and Optimization of Novel mTOR Inhibitors for Radiosensitization of Hepatocellular Carcinoma.

Authors:  Ying-Qi Feng; Shuang-Xi Gu; Yong-Shou Chen; Xu-Dong Gao; Yi-Xin Ren; Jian-Chao Chen; Yin-Ying Lu; Heng Zhang; Shuang Cao
Journal:  Drug Des Devel Ther       Date:  2020-05-08       Impact factor: 4.162

3.  Prognostic Significance of Apparent Diffusion Coefficient in Hepatocellular Carcinoma Patients treated with Stereotactic Ablative Radiotherapy.

Authors:  Cheng-Hsiang Lo; Wen-Yen Huang; Chih-Weim Hsiang; Meei-Shyuan Lee; Chun-Shu Lin; Jen-Fu Yang; Hsian-He Hsu; Wei-Chou Chang
Journal:  Sci Rep       Date:  2019-10-02       Impact factor: 4.379

4.  Outcomes of patients presenting with elevated tumor marker levels but negative gadoxetic acid-enhanced liver MRI after a complete response to hepatocellular carcinoma treatment.

Authors:  Ka Eun Kim; Dong Hyun Sinn; Moon Seok Choi; Honsoul Kim
Journal:  PLoS One       Date:  2022-01-27       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.